Liver Cancer
Radiofrequency ablation deemed effective for unresectable hepatocellular cancer
Published in Cancer Weekly, January 10th, 2006
"The long-term outcome of RFA for unresectable HCC has not been reported. This study was performed to evaluate the long-term survival of patients with unresectable HCC after RFA and to identify possible factors that might affect survival," investigators in the United States reported.
"In this prospective study, 65 patients with unresectable HCC who underwent RFA were followed. A total of 84 RFA operations were performed percutaneously (n=49), laparoscopically (n=20), or by open surgery (n=15), to ablate 191 tumors. Twenty-two patients died within 16...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-01-10)
More Articles from Cancer Weekly
- Cancer Risk Factors
Effects of gestational mutations on cancer risk assessed by mathematical formula - Diet & Nutrition
Human milk found to protect against gastric cancer - Disease Associations
Family history of hematopoietic malignancy related to higher risk of lymphoma - Head & Neck Cancer
Betel quid chewing may contribute to pharyngeal and laryngeal carcinogenesis - Acute Lymphoblastic Leukemia
European study confirms efficacy of clofarabine in pediatric patients with ALL - Acute Myeloid Leukemia
Acute myeloid leukemia blasts regularly express PRR1 and PRR2 - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
